Neville Rodie & Shaw’s Neurotrope, Inc. Common NTRP Stock Holding History

Neville Rodie & Shaw’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-109,375	Closed	-$121K	–	262
2020 Q3	$121K	Hold	109,375	–	–	0.01%	240
2020 Q2	$127K	Hold	109,375	–	–	0.01%	237
2020 Q1	$90K	Hold	109,375	–	–	0.01%	220
2019 Q4	$107K	Hold	109,375	–	–	0.01%	243
2019 Q3	$89K	Hold	109,375	–	–	0.01%	237
2019 Q2	$877K	Hold	109,375	–	–	0.09%	134
2019 Q1	$596K	Hold	109,375	–	–	0.06%	156
2018 Q4	$390K	Hold	109,375	–	–	0.05%	178
2018 Q3	$964K	Hold	109,375	–	–	0.1%	127
2018 Q2	$1.06M	Buy	+109,375	New	+$1.01M	0.11%	124

Other funds holding NTRP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Neville Rodie & Shaw's NTRP Position: Q4 2020 in Review

Neville Rodie & Shaw sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 109,375 shares — an estimated $121K sold.

Neville Rodie & Shaw first reported a position in NTRP in Q2 2018 and held it in 10 quarters. The position peaked at $1.06M in Q2 2018. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

Neville Rodie & Shaw reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
Neville Rodie & Shaw sold 109,375 Neurotrope, Inc. Common shares in Q4 2020, an estimated $121K.
Neville Rodie & Shaw first reported a position in Neurotrope, Inc. Common in Q2 2018 and held it in 10 quarters.
Neville Rodie & Shaw's Neurotrope, Inc. Common position peaked at $1.06M in Q2 2018.
1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Neville Rodie & Shaw's 13F filing for Q4 2020, filed 4 Mar 2021.